Crescentis Capital
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Crescentis Capital's fund-raising committee approved the terms of its rights issue, offering 1,02,08,129 equity shares at Rs78 each for aggregate proceeds of Rs79.62 crore on full subscription. The offer was set in a ratio of three shares for every five held on the November 4 record date, with subscription scheduled from November 16 to November 27. The board had proposed an up-to-Rs80 crore rights issue in May and filed draft offer documents in September with the price and ratio pending, receiving BSE in-principle approval on October 23. A Rs49.04 crore rights issue completed the prior year was fully utilised. The company closed the year to March with net loans of Rs45.95 crore and total income of Rs1.55 crore.
Powered by Tijori
Crescentis Capital's fund-raising committee approved the terms of its rights issue, offering 1,02,08,129 equity shares at Rs78 each for aggregate proceeds of Rs79.62 crore on full subscription. The offer was set in a ratio of three shares for every five held on the November 4 record date, with subscription scheduled from November 16 to November 27. The board had proposed an up-to-Rs80 crore rights issue in May and filed draft offer documents in September with the price and ratio pending, receiving BSE in-principle approval on October 23. A Rs49.04 crore rights issue completed the prior year was fully utilised. The company closed the year to March with net loans of Rs45.95 crore and total income of Rs1.55 crore.
Powered by Tijori
Oct 29 (Reuters) - Som Datt Finance Corporation Ltd SDFC.BO:
TO CONSIDER RAISING OF FUNDS VIA MODES INCLUDING QIP
Source text: ID:nBSE6Nc7tX
Further company coverage: SDFC.BO
(([email protected];;))
Oct 29 (Reuters) - Som Datt Finance Corporation Ltd SDFC.BO:
TO CONSIDER RAISING OF FUNDS VIA MODES INCLUDING QIP
Source text: ID:nBSE6Nc7tX
Further company coverage: SDFC.BO
(([email protected];;))
Dec 8 (Reuters) - Som Datt Finance Corporation Ltd SDFC.BO:
VISHAL MANDAVGADE HAS TENDERED RESIGNATION FROM POST OF CFO
Source text for Eikon: ID:nBSE785fNd
Further company coverage: SDFC.BO
(([email protected];;))
Dec 8 (Reuters) - Som Datt Finance Corporation Ltd SDFC.BO:
VISHAL MANDAVGADE HAS TENDERED RESIGNATION FROM POST OF CFO
Source text for Eikon: ID:nBSE785fNd
Further company coverage: SDFC.BO
(([email protected];;))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Crescentis Capital do?
Som Datt Finance Corporation Ltd. started as an NBFC in 1993, specializing in retail finance for cars and construction equipment. It obtained a license from the RBI to operate as a Non-Financial Banking company in 2000.
Who are the competitors of Crescentis Capital?
Crescentis Capital major competitors are Team India Guaranty, Kartik Invests.Trust, IL&FS Invest.Manager, Bombay Oxygen Inv., Gourmet Gateway Ind, Tilak Ventures, Inference Platforms. Market Cap of Crescentis Capital is ₹222 Crs. While the median market cap of its peers are ₹195 Crs.
Is Crescentis Capital financially stable compared to its competitors?
Crescentis Capital seems to be less financially stable compared to its competitors. Altman Z score of Crescentis Capital is 9.2 and is ranked 4 out of its 8 competitors.
Does Crescentis Capital pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Crescentis Capital latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Crescentis Capital allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Crescentis Capital balance sheet?
Balance sheet of Crescentis Capital is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Crescentis Capital improving?
Yes, profit is increasing. The profit of Crescentis Capital is ₹0.56 Crs for TTM, -₹2.53 Crs for Mar 2026 and -₹5.42 Crs for Mar 2025.
Is the debt of Crescentis Capital increasing or decreasing?
The net debt of Crescentis Capital is decreasing. Latest net debt of Crescentis Capital is -₹7.15 Crs as of Sep-26. This is less than Mar-26 when it was ₹11.64 Crs.
Is Crescentis Capital stock expensive?
Yes, Crescentis Capital is expensive. Latest PE of Crescentis Capital is 395, while 3 year average PE is 101. Also latest EV/EBITDA of Crescentis Capital is 93.78 while 3yr average is 56.62.
Has the share price of Crescentis Capital grown faster than its competition?
Crescentis Capital has given better returns compared to its competitors. Crescentis Capital has grown at ~39.95% over the last 10yrs while peers have grown at a median rate of 16.28%
Is the promoter bullish about Crescentis Capital?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Crescentis Capital is 74.98% and last quarter promoter holding is 74.98%.
Are mutual funds buying/selling Crescentis Capital?
There is Insufficient data to gauge this.